Molecular Templates Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Molecular Templates's estimated annual revenue is currently $2147.5M per year.
- Molecular Templates's estimated revenue per employee is $9,896,238
- Molecular Templates's total funding is $93.5M.
- Molecular Templates has 217 Employees.
- Molecular Templates grew their employee count by 27% last year.
- Molecular Templates currently has 22 job openings.
What Is Molecular Templates?
Molecular Templates (MTEM) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB) platform. MTEM's first immunotoxin, MT-3724, is in clinical development for non-Hodgkin's lymphoma. Pipeline products for additional oncology targets are being advanced toward clinical development. For more information, please visit MTEM's website at www.mtem.com.keywords:N/A